Tjasso Blokzijl

3.7k total citations · 1 hit paper
56 papers, 2.9k citations indexed

About

Tjasso Blokzijl is a scholar working on Molecular Biology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Tjasso Blokzijl has authored 56 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 17 papers in Immunology and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Tjasso Blokzijl's work include Lymphoma Diagnosis and Treatment (15 papers), Inflammatory Bowel Disease (11 papers) and Cancer-related molecular mechanisms research (7 papers). Tjasso Blokzijl is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Inflammatory Bowel Disease (11 papers) and Cancer-related molecular mechanisms research (7 papers). Tjasso Blokzijl collaborates with scholars based in Netherlands, United States and Germany. Tjasso Blokzijl's co-authors include Anke van den Berg, Sibrand Poppema, Debora de Jong, Joost Kluiver, S. Jacobs, Bart‐Jan Kroesen, Geert Harms, Frank M. Raaphorst, Elly Fieret and Chris J.L.M. Meijer and has published in prestigious journals such as Nature Communications, Blood and The Journal of Immunology.

In The Last Decade

Tjasso Blokzijl

53 papers receiving 2.8k citations

Hit Papers

BIC and miR‐155 are highly expressed in Hodgkin, primary ... 2005 2026 2012 2019 2005 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tjasso Blokzijl Netherlands 25 2.0k 1.2k 492 416 329 56 2.9k
Pieter Van Vlierberghe Belgium 32 2.7k 1.4× 1.5k 1.2× 604 1.2× 646 1.6× 290 0.9× 113 4.5k
Xiaosheng Wu United States 29 1.5k 0.8× 442 0.4× 683 1.4× 574 1.4× 301 0.9× 81 2.7k
Alfons Navarro Spain 36 3.1k 1.5× 2.7k 2.2× 292 0.6× 522 1.3× 311 0.9× 102 4.0k
Takanori Eguchi Japan 31 2.1k 1.1× 923 0.8× 260 0.5× 413 1.0× 117 0.4× 79 2.8k
Claudia D. Andl United States 26 1.5k 0.7× 612 0.5× 259 0.5× 772 1.9× 258 0.8× 56 2.8k
Jenny Wu United States 11 1.1k 0.6× 715 0.6× 169 0.3× 693 1.7× 189 0.6× 14 2.3k
Dalya R. Soond United Kingdom 16 1.7k 0.8× 1.2k 1.0× 1.4k 2.9× 507 1.2× 141 0.4× 17 3.1k
Hiroaki Ikushima Japan 13 1.5k 0.7× 491 0.4× 523 1.1× 855 2.1× 155 0.5× 30 2.3k
Agustí Toll Spain 24 1.2k 0.6× 904 0.7× 217 0.4× 655 1.6× 226 0.7× 92 2.7k
Yan Teng China 25 1.3k 0.6× 506 0.4× 269 0.5× 354 0.9× 92 0.3× 71 1.9k

Countries citing papers authored by Tjasso Blokzijl

Since Specialization
Citations

This map shows the geographic impact of Tjasso Blokzijl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tjasso Blokzijl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tjasso Blokzijl more than expected).

Fields of papers citing papers by Tjasso Blokzijl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tjasso Blokzijl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tjasso Blokzijl. The network helps show where Tjasso Blokzijl may publish in the future.

Co-authorship network of co-authors of Tjasso Blokzijl

This figure shows the co-authorship network connecting the top 25 collaborators of Tjasso Blokzijl. A scholar is included among the top collaborators of Tjasso Blokzijl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tjasso Blokzijl. Tjasso Blokzijl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuente, Marjorie De la, Karen Dubois‐Camacho, Glauben Landskron, et al.. (2025). Butyrate suppresses mucosal inflammation in inflammatory bowel disease primarily through HDAC3 inhibition in monocytes and macrophages. FEBS Journal. 292(22). 6134–6157. 1 indexed citations
2.
Kats‐Ugurlu, Gürsah, et al.. (2024). Chronic Allograft Enteropathy Treated with Vedolizumab: A Case Report. Transplantation Proceedings. 57(1). 148–155.
4.
Fagundes, Raphael R., Arno R. Bourgonje, Shixian Hu, et al.. (2022). HIF1α-Dependent Induction of TFRC by a Combination of Intestinal Inflammation and Systemic Iron Deficiency in Inflammatory Bowel Disease. Frontiers in Physiology. 13. 889091–889091. 13 indexed citations
5.
Fagundes, Raphael R., Arno R. Bourgonje, Ali Saeed, et al.. (2021). Inulin-grown Faecalibacterium prausnitzii cross-feeds fructose to the human intestinal epithelium. Gut Microbes. 13(1). 1993582–1993582. 24 indexed citations
6.
Kats‐Ugurlu, Gürsah, Tjasso Blokzijl, Gilles F.H. Diercks, et al.. (2020). Safe and Successful Treatment of Acute Cellular Rejection of an Intestine and Abdominal Wall Transplant With Vedolizumab. Transplantation Direct. 6(2). e527–e527. 18 indexed citations
7.
Imhann, Floris, Haukeline H. Volders, Tjasso Blokzijl, et al.. (2016). HSPA6 is an ulcerative colitis susceptibility factor that is induced by cigarette smoke and protects intestinal epithelial cells by stabilizing anti-apoptotic Bcl-XL. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(4). 788–796. 15 indexed citations
8.
Haaften, Wouter T. van, Henri G. D. Leuvenink, Rutger J. Ploeg, et al.. (2014). Histopathologic and molecular evaluation of the Organ Procurement and Transplantation Network selection criteria for intestinal graft donation. Journal of Surgical Research. 189(1). 143–151. 10 indexed citations
9.
Parikh, Kaushal, Lu Zhou, Rajesh Somasundaram, et al.. (2014). Suppression of p21Rac Signaling and Increased Innate Immunity Mediate Remission in Crohn’s Disease. Science Translational Medicine. 6(233). 233ra53–233ra53. 26 indexed citations
10.
Logt, Elise M.J. van der, Tjasso Blokzijl, Roelof van der Meer, Klaas Nico Faber, & Gerard Dijkstra. (2012). Westernized high-fat diet accelerates weight loss in dextran sulfate sodium-induced colitis in mice, which is further aggravated by supplementation of heme. The Journal of Nutritional Biochemistry. 24(6). 1159–1165. 45 indexed citations
11.
Gibcus, Johan H., Geert Harms, Debora de Jong, et al.. (2009). Hodgkin Lymphoma Cell Lines Are Characterized by a Specific miRNA Expression Profile. Neoplasia. 11(2). 167–IN9. 117 indexed citations
12.
Wang, Mindy, Kirsten van Lom, G. Harms, et al.. (2008). miRNA analysis in B‐cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR‐150 and high BIC /miR‐155 expression. The Journal of Pathology. 215(1). 13–20. 92 indexed citations
13.
Boelens, Mirjam C., Gerard J. te Meerman, Johan H. Gibcus, et al.. (2007). Microarray amplification bias: loss of 30% differentially expressed genes due to long probe – poly(A)-tail distances. BMC Genomics. 8(1). 277–277. 16 indexed citations
14.
Kok, Klaas, Joost Kluiver, Eva van den Berg, et al.. (2006). BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma–derived cell line DEV. Human Pathology. 37(6). 675–683. 24 indexed citations
15.
Kluiver, Joost, Klaas Kok, Ines Pfeil, et al.. (2006). Global correlation of genome and transcriptome changes in classical Hodgkin lymphoma. Hematological Oncology. 25(1). 21–29. 19 indexed citations
16.
Blokzijl, Tjasso, Geert Harms, Megan S. Lim, et al.. (2005). TIMP‐1 expression in anaplastic large cell lymphoma is usually restricted to macrophages and only seldom observed in tumour cells. The Journal of Pathology. 206(4). 445–450. 6 indexed citations
17.
Poppema, Sibrand, et al.. (2005). Expression of the T-Cell Transcription Factors, GATA-3 and T-bet, in the Neoplastic Cells of Hodgkin Lymphomas. American Journal Of Pathology. 166(1). 127–134. 48 indexed citations
18.
Berg, Anke van den, Tjasso Blokzijl, Geert Harms, et al.. (2004). Dimeric galectin‐1 induces IL‐10 production in T‐lymphocytes: an important tool in the regulation of the immune response. The Journal of Pathology. 204(5). 511–518. 78 indexed citations
19.
Raaphorst, Frank M., Arie P. Otte, Folkert J. van Kemenade, et al.. (2001). Distinct BMI-1 and EZH2 Expression Patterns in Thymocytes and Mature T Cells Suggest a Role for Polycomb Genes in Human T Cell Differentiation. The Journal of Immunology. 166(10). 5925–5934. 62 indexed citations
20.
Raaphorst, Frank M., Folkert J. van Kemenade, Tjasso Blokzijl, et al.. (2000). Coexpression of BMI-1 and EZH2 Polycomb Group Genes in Reed-Sternberg Cells of Hodgkin’s Disease. American Journal Of Pathology. 157(3). 709–715. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026